TTrialPathMatch Me to Trials
← Back to trials
RecruitingIVFEndometrioma

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

Eligible age

18–41 yrs

Accepts

Women

Locations

0 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.

Sponsor: Hillel Yaffe Medical Center

You may qualify if…

  • A woman with endometrioma with a diameter of 25-100 mm

You may not qualify if…

  • Other causes of infertility (sperm disorder, ovulation disorder, uterine disorder, mechanical factor, poor ovarian reserve)

Source: ClinicalTrials.gov · NCT06971458 · last updated 2025-05-14

Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol · TrialPath